References
- Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 1952; 40: 346
- Bailar J. C. Thromboembolism and oestrogen therapy. Lancet 1967; 2: 560
- Brakman P. Fibrinolysis. A Standardized Fibrin Plate Method and a Fibrinolytic Assay of Plasminogen. Scheltema & Holkema, Amsterdam 1967
- Brakman P., Sobrero A. J., Astrup T. Effects of different systemic contraceptives on blood fibrinolysis. Amer J Obstet Gynec 1970; 106: 187
- Butler C., Hill H. Chlormadinone acetate as oral contraceptive. Lancet 1969; 1: 1116
- Daniel D. G., Campbell H., Turnbull A. C. Puerperal thromboembolism and suppression of lactation. Lancet 1967; 2: 287
- Horne C. H. W., Mallinson A. C., Ferguson J., Goudje R. B. Effects of oestrogen and progestogen on serum levels of alpha-2-macroglobulin, transferrin, albumin, and IgG. J Clin Path 1971; 24: 464
- Howie P. W., Mallinson A. C., Prentice C. R. M., Home C. H. W., McNicol G. P. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and anti-thrombin activity. Lancet 1970; 2: 1329
- Inman W. H. W., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the committee on safety of drugs. Brit Med J 1970; 2: 203
- Isacson S., Nilsson I. M. Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis. Acta Chir Scand
- Jeffcoate T. N. A., Miller J., Roos R. F., Tindall V. R. Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy. Brit Med J 1968; 4: 19
- Laurell C.-B., Kullander S., Thorell J. Plasma proteins after continuous oral use of a progestogen—chlormadinone acetate—as a contraceptive. Scand J Clin Lab Invest 1969; 24: 387
- Menon S., Peberdy M., Rannie G. H., Weightman D., Dewar H. A. A comparative study of blood fibrinolytic activity in normal women, pregnant women and women on oral contraceptives. J Obstet Gynaec Brit Comm 1970; 77: 752
- Nilsson I. M. Blödnings- och trombossjukdomar. Almqvist & Wiksell. 1971
- Nilsson I. M., Kullander S., Åstedt B. Coagulation and fibrinolytic studies during continuous use of low dose gestagen. Acta Endocrin 1970; 65: 111
- Nilsson I. M., Olow B. Determination of fibrinogen and fibrinogenolytic activity. Thrombos Diathes Haemorrh 1962; 8: 297
- Oliver M. F. Thrombosis and oestrogens. Lancet 1967; 2: 510
- Pandolfi M., Nilsson I. M., Robertson B., Isacson S. Fibrinolytic activity of human veins. Lancet 1967; 2: 127
- Pandolfi M., Åstedt B., Nilsson I. M. Histo-chemical assay of tissue plasminogen activator in vein walls—a standard method. Thrombos Diathes Haemorrh
- Poller L., Thomson J. M., Thomas W., Wray C. Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study. Brit Med J 1971; 1: 705
- Powell L. C., Seymor R. J. Effects of depomedroxyprogesterone acetate as a contraceptive agent. Amer J Obstet Gynec 1971; 110: 36
- Robertson B. R. On thrombosis, thrombolysis and fibrinolysis. Acta Chir Scand 1971, Suppl. 421
- Scowen E. F. Oral contraceptives containing oestrogens. Brit Med J 1969; 4: 744
- “Today's drugs”. Changing oral contraceptives. Brit Med J 1969; 4: 789
- Todd A. S. Histological localization of fibrinolysin activator. J Path Bact 1959; 78: 281
- Åstedt B. Low fibrinolytic activity of veins during treatment with ethinyloestradiol. Acta Obstet Gynec Scand 1971; 50: 279
- Åstedt B., Jeppsson S., Pandolfi M. Fibrinolytic activity of veins during use of medroxyprogesterone acetate as a contraceptive. Fertility and Sterility